Business Description
Gaush Meditech Ltd
ISIN : KYG3902N1051
Compare
Compare
Traded in other countries / regions
02407.Hong KongF7Y.Germany IPO Date
2022-12-12Description
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.25 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | -3.5 | |||||
Interest Coverage | 7.03 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.68 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.5 | |||||
3-Year EBITDA Growth Rate | 28 | |||||
3-Year EPS without NRI Growth Rate | 3.8 | |||||
3-Year FCF Growth Rate | 13.5 | |||||
3-Year Book Growth Rate | 292.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 5.24 | |||||
9-Day RSI | 8.39 | |||||
14-Day RSI | 13.34 | |||||
6-1 Month Momentum % | -59.19 | |||||
12-1 Month Momentum % | -68.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.93 | |||||
Days Inventory | 330.69 | |||||
Days Sales Outstanding | 83.8 | |||||
Days Payable | 92.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 10.16 | |||||
Forward Dividend Yield % | 10.16 | |||||
5-Year Yield-on-Cost % | 10.16 | |||||
Shareholder Yield % | 19.3 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.91 | |||||
Operating Margin % | 22.85 | |||||
Net Margin % | -44.16 | |||||
FCF Margin % | 18.89 | |||||
ROE % | -19.05 | |||||
ROA % | -10.8 | |||||
ROIC % | 9.75 | |||||
ROC (Joel Greenblatt) % | -87.6 | |||||
ROCE % | -10.93 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.49 | |||||
PE Ratio without NRI | 8.65 | |||||
Price-to-Owner-Earnings | 7.28 | |||||
PS Ratio | 2.13 | |||||
PB Ratio | 0.87 | |||||
Price-to-Tangible-Book | 3.27 | |||||
Price-to-Free-Cash-Flow | 11.27 | |||||
Price-to-Operating-Cash-Flow | 9.04 | |||||
EV-to-EBIT | -6.27 | |||||
EV-to-EBITDA | -7.45 | |||||
EV-to-Revenue | 2.05 | |||||
EV-to-FCF | 10.85 | |||||
Price-to-Graham-Number | 1.12 | |||||
Price-to-Net-Current-Asset-Value | 6.46 | |||||
Earnings Yield (Greenblatt) % | -15.95 | |||||
FCF Yield % | 8.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gaush Meditech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 754.8 | ||
EPS (TTM) (HK$) | 1.279 | ||
Beta | 0 | ||
Volatility % | 38.4 | ||
14-Day RSI | 13.34 | ||
14-Day ATR (HK$) | 0.722815 | ||
20-Day SMA (HK$) | 13.119 | ||
12-1 Month Momentum % | -68.16 | ||
52-Week Range (HK$) | 10.78 - 48.15 | ||
Shares Outstanding (Mil) | 147.97 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Gaush Meditech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Gaush Meditech Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Gaush Meditech Ltd Frequently Asked Questions
What is Gaush Meditech Ltd(HKSE:02407)'s stock price today?
The current price of HKSE:02407 is HK$10.86. The 52 week high of HKSE:02407 is HK$48.15 and 52 week low is HK$10.78.
When is next earnings date of Gaush Meditech Ltd(HKSE:02407)?
The next earnings date of Gaush Meditech Ltd(HKSE:02407) is .
Does Gaush Meditech Ltd(HKSE:02407) pay dividends? If so, how much?
The Dividend Yield %  of Gaush Meditech Ltd(HKSE:02407) is 10.16% (As of Today), Highest Dividend Payout Ratio of Gaush Meditech Ltd(HKSE:02407) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Gaush Meditech Ltd(HKSE:02407) is 10.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |